The policy analysis and guidance you need by the experts you trust, daily.
- After Hours
- Agent Oversight
- Brain Food
- Health Insurance Exchanges
- Part D
- Performance Optimization
- Policy & Health Reform
- Prospective Evaluations
- Provider Relations
- Risk Adjustment
- Sales & Marketing
- Star Ratings
- Alan Mittermaier on MA and Part D Proposed Rule Increases Plan Flexibility, Reduces Regulatory Burden
- Sharon Willliams on A New Source of Capital for Star Ratings and Clinical Innovations
- William on Will Trump and Price Pull Out the Scalpels for Star Ratings?
- Bobby on January Release of the Draft MMG – Perfect Timing
- Pam Lassila on Best Practices and Common Conditions of Audit Preparation
The Voice of Olga Walther
With the tax reform bill just the tip of the iceberg, Congress faces a daunting agenda for the remainder of the year. Below are some healthcare-related agenda items Congress will need to take up in the next few weeks.
The Centers for Medicare & Medicaid Services (CMS) recently released the highly anticipated Medicare Advantage (MA) and Prescription Drug Benefit Program (Part D) Proposed Rule for 2019. A big focus of the proposed regulation included increasing plan flexibility and reducing regulatory burden. Comments on the proposed rule are due to CMS by January 16, 2018.
As CMS Administrator Verma Announces Obama-Era Medicaid Policy Reversals, States Signal Support for Medicaid Expansion
Tuesday was a big day for Medicaid policy, with both a rollback of Obama Era policy reversals and a movement toward more states adopting Obamacare’s Medicaid Expansion.
With two months of Affordable Care Act (ACA) stabilization bill efforts under the belt, it is becoming questionable whether Congress will be able to pass, or even bring to the floor, a bill President Trump will support and sign. We saw some developments this week that may shape the future of cost sharing subsidy payments as well as any other ACA fixes in the months to come.
Congress moved beyond considering the Affordable Care Act (ACA). From potential changes to the Medicare Advantage (MA) program to necessary extensions of already existing Medicare programs, Congress had a busy working week moving the healthcare agenda.
The packed agenda for Congress promised us a whirlwind of a month, and it certainly came with its share of surprises. Despite the appearance of progress, however, we still don’t have answers to any of the pressing healthcare legislation questions as we conclude our third week of September. With one week remaining, action looks pretty grim for many of the government health programs, including the Children’s Health Insurance Program (CHIP) and the Affordable Care Act (ACA), mainly due to the sudden resurgence of ACA repeal talks.
On Wednesday, September 6, the Senate HELP Committee kicked off a series of hearings on a possible bipartisan bill to address pressing issues with the individual market under the Affordable Care Act (ACA). The first hearing, the senators heard from five state insurance commissioners from both parties. Notably, the hearing largely avoided partisan rhetoric on the ACA and focused on how substantive short-term solutions should be implemented. Senator Alexander expressed his wish for draft legislation to be introduced next week. More importantly, further insight into what senators may agree on was provided in the first hearing.